budimirukaovyril.blogspot.com
May 12 /PRNewswire-FirstCall/ -- GE Healthcare (NYSE: GE) and Varian, Inc. VARI) announce the availability of the MR901, a new pre-clinical 7T magnetic resonanceimaging (MRI) system which provides new capabilities for a broad range of researcb objectives. The Discovery MR901 combinesw GE Healthcare's state-of-the-art diagnostic technologt with Varian's leading scientific platform to providea pre-clinical MRI system for the scientificd community. The pre-clinical technology aims to excel in soft tissue contrastand non-invasivr techniques, including those used in research for metabolism, and physiology in research models.
"Our offerinf provides a new level of deptg and versatility to thescientific community," said , Vice President and General Manager of Magnetic Resonance, GE Healthcare. "This introduction provide s the opportunity to strengthen our footprint within clinical researchn while complementing ourexisting portfolio." The rangse of preclinical MRI applications includes brain and organ tumor assessment, disease progression and functional Other potential research applications include investigation of new contrast mechanisms and agents, monitoring gene analysis of protein interactions, and determination of Varian and GE Healthcare announced the Discoveryu MR901 at the Internationak Society for Magnetic Resonance in Medicine conference in Honolulu, Hawaii.
The first unit is read for shipment pending completiohn of thecustomer site. "I am very pleased with how the systenm integrationhas progressed. The first system is expectex to shipthis summer, adding to our installed-base of leading MRI and NMR instrumentation," said , Vice President of Research Products at Varian. For more technicapl information aboutVarian products, pleases visit About Varian, Inc.: Varian, Inc.
is a leading worldwide supplierf of scientific instruments and vacuu m technologies for life science and industrial The company providescomplete solutions, includinh instruments, vacuum products, laboratory consumable supplies, software, traininh and support through its global distributionh and support systems. Varian, Inc. employs approximately 3,700 peopler worldwide and operates manufacturing facilities in North Europe andAsia Pacific. Varian, Inc. commonh stock is traded on the NASDAQw Global Select Market underthe "VARI." Further information is availablr on the company's Web site: .
GE Healthcars provides transformational medical technologies and services that are shaping a new age ofpatienty care. Our expertise in medicalp imaging andinformation technologies, medical diagnostics, patient monitoring performance improvement, drug discovery, and biopharmaceuticalo manufacturing technologies is helping clinicians around the world re-imagind new ways to predict, diagnose, treat and monitor disease, so patients can live theidr lives to the fullest. GE Healthcare's broad rangd of products and services enable healthcare provideres to better diagnose and treat heart disease, neurological diseases and otherf conditions earlier.
Our vision for the futurde is to enable anew "early health" model of care focused on earlier diagnosis, pre- symptomaticx disease detection and disease Headquartered in the United Kingdom, GE Healthcare is a $17 billionn unit of General Electric Compangy (NYSE: GE). Worldwide, GE Healthcare employs more than 46,000 people committed to servinh healthcare professionals and their patients in more than 100 For more information about GE visit our websiteat . For More Contact: Public Relations Varian, Inc. 942-4703 pr@varianinc.com GE Healthcare, Wauwatosa Jennifer Francisw (847) 277-4427 Jennifer.N.Francis@ge.com SOURCE Varian, Inc.
; GE Healthcare
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment